
AVALO THERAPEUT. DL-,001
Acción · US05338F3064 · AVTX · A3E2FR (XNCM)
4,20 EUR
13.06.2025 19:59
Cotizaciones actuales de AVALO THERAPEUT. DL-,001
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria |
---|---|---|---|---|---|
![]() NASDAQ |
AVTX
|
USD
|
13.06.2025 19:59
|
4,85 USD
| 4,87 USD
-0,41 %
|
Rendimiento
Día | Semana | Mes | 3 meses | 6 meses | 1 año | 5 años |
---|---|---|---|---|---|---|
0,57 % | 18,13 % | 32,35 % | -35,40 % | -52,49 % | -58,89 % | -99,93 % |
Perfil de la empresa para AVALO THERAPEUT. DL-,001 Acción
Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the treatment of non-eosinophilic asthma, as well as inflammatory bowel disease, including moderate to severe Crohn's disease, and ulcerative colitis; and Phase III clinical trial for the treatment of COVID-19 acute respiratory distress syndrome. The company also engages in developing AVTX-007, a fully human Anti-IL-18 monoclonal antibody that is under Phase I clinical trial for the treatment of still's disease, including adult-onset still's disease and systemic juvenile idiopathic arthritis. Its products for rare genetic diseases in Phase III clinical trials include AVTX-801, a D-galactose substrate replacement therapy for the treatment of phosphoglucomutase 1 deficiency (PGM1), also known as PGM1-CDG; and AVTX-803, a L-fucose substrate replacement therapy for the treatment of LADII, also known as SLC35C1-CDG. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland.
Datos de la empresa
Nombre AVALO THERAPEUT. DL-,001
Empresa Avalo Therapeutics, Inc.
Símbolo AVTX
Sitio web
https://www.avalotx.com
Mercado principal
Frankfurt

WKN A3E2FR
ISIN US05338F3064
Tipo de valor Acción
Sector Healthcare
Industria Biotechnology
CEO Dr. Garry A. Neil M.D.
Capitalización de mercado 51 Mio
País Estados Unidos de América
Moneda EUR
Empleados 0,0 T
Dirección 540 Gaither Road, 20850 Rockville
Fecha de OPV 2015-10-14
Cambios de identificador
Fecha | De | A |
---|---|---|
26.08.2021 | CERC | AVTX |
Símbolos de cotización
Nombre | Símbolo |
---|---|
Frankfurt | C6K0.F |
NASDAQ | AVTX |
Otras acciones
Los inversores que tienen AVALO THERAPEUT. DL-,001 también tienen las siguientes acciones en su cartera:
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras.
Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.